7 HLTH Announcements You Don’t Want to Miss

As always, this year’s HLTH conference brought a slew of announcements — from product launches to funding rounds to new partnerships. This list features short summaries for seven of the conference’s most notable announcements. The post 7 HLTH Announcements You Don’t Want to Miss appeared first on MedCity News.

Read More

How to write a good grant proposal

How do you write a good grant proposal? How do you write a good proposal for any type of project? Jim Olds– the former head of NSF’s Biological Sciences Directorate –provides some fantastic advice in his post “What Grant Reviewers Actually Look For (and What They Ignore)“. He distills what grant reviewers want into 5…

Read More

Is Optum Real For Real?

Providers increasingly accuse payers of delaying and denying reimbursement for claims. Now, UnitedHealth Group’s Optum subsidiary is hoping to change the dynamic through what they claim is a real-time claims management program leveraging tech. The post Is Optum Real For Real? appeared first on MedCity News.

Read More

Ventyx Bio Cardiovascular Drug’s Phase 2 Results Set Up Talks With a Big Pharma Firm

In a placebo-controlled mid-stage study, Ventyx Biosciences’ oral NLRP3 inhibitor led to rapid and sustained reductions in levels of a protein that’s an indicator of cardiovascular disease risk. The brain-penetrating properties of this once-daily pill also have potential applications addressing inflammation that drives neurodegenerative disorders. The post Ventyx Bio Cardiovascular Drug’s Phase 2 Results Set…

Read More